Pragmatic medicine in solid cancer: a translational alternative to precision medicine.

Onco Targets Ther · 2016 · PMC4827419 · PMID 27103822

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

a nonsignificant trendP =0.054so close (0.05 < p ≤ 0.1)

Overall survival (OS) showed a nonsignificant trend in favor of continuing TKI therapy (33.0 vs 21.2 months, P =0.054).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.